Atria Wealth Solutions Inc. grew its position in shares of MetLife, Inc. (NYSE:MET - Free Report) by 42.6% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 25,541 shares of the financial services provider's stock after purchasing an additional 7,628 shares during the quarter. Atria Wealth Solutions Inc.'s holdings in MetLife were worth $2,091,000 as of its most recent SEC filing.
Several other institutional investors have also recently modified their holdings of MET. MeadowBrook Investment Advisors LLC grew its position in MetLife by 244.4% during the 3rd quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider's stock worth $26,000 after acquiring an additional 220 shares during the last quarter. Carmichael Hill & Associates Inc. grew its position in MetLife by 131.9% during the 3rd quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider's stock worth $27,000 after acquiring an additional 186 shares during the last quarter. Peterson Financial Group Inc. bought a new position in MetLife during the 3rd quarter worth approximately $30,000. Retirement Wealth Solutions LLC purchased a new stake in MetLife in the 4th quarter worth approximately $32,000. Finally, Sierra Ocean LLC purchased a new stake in MetLife in the 4th quarter worth approximately $32,000. 94.99% of the stock is currently owned by institutional investors.
Several equities research analysts have weighed in on MET shares. StockNews.com cut MetLife from a "buy" rating to a "hold" rating in a report on Thursday, January 9th. Keefe, Bruyette & Woods dropped their price objective on MetLife from $100.00 to $98.00 and set an "outperform" rating for the company in a report on Wednesday, February 12th. Barclays dropped their price objective on MetLife from $96.00 to $95.00 and set an "overweight" rating for the company in a report on Friday, February 7th. TD Cowen raised their target price on MetLife from $97.00 to $99.00 and gave the company a "buy" rating in a research note on Wednesday, November 27th. Finally, JPMorgan Chase & Co. raised their target price on MetLife from $86.00 to $88.00 and gave the company an "overweight" rating in a research note on Tuesday, January 7th. Two investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $92.58.
Get Our Latest Report on MetLife
MET stock traded down $1.73 on Friday, reaching $81.02. 3,282,193 shares of the company traded hands, compared to its average volume of 3,504,177. MetLife, Inc. has a one year low of $67.30 and a one year high of $89.05. The company has a debt-to-equity ratio of 0.54, a current ratio of 0.16 and a quick ratio of 0.16. The company has a market cap of $56.10 billion, a P/E ratio of 13.57, a price-to-earnings-growth ratio of 0.65 and a beta of 1.07. The firm has a fifty day simple moving average of $83.41 and a 200-day simple moving average of $81.44.
MetLife (NYSE:MET - Get Free Report) last posted its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $2.08 earnings per share for the quarter, missing analysts' consensus estimates of $2.13 by ($0.05). MetLife had a net margin of 6.19% and a return on equity of 20.42%. Research analysts anticipate that MetLife, Inc. will post 9.65 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, March 11th. Shareholders of record on Tuesday, February 4th will be issued a $0.545 dividend. This represents a $2.18 dividend on an annualized basis and a dividend yield of 2.69%. The ex-dividend date is Tuesday, February 4th. MetLife's payout ratio is 36.52%.
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Before you consider MetLife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.
While MetLife currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.